Differing effects of antihypertensive agents on urinary albumin excretion

American Journal of Nephrology

Volumn 16, Issue 3, 1996, Pages 237-245

  Weir, M R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antihypertensives; Diabetic renal diasease; Hypertension; Nondiabetic renal disease; Urinary albumin excretion

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTERIAL PRESSURE; DIABETIC NEPHROPATHY; ESSENTIAL HYPERTENSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REVIEW; URINARY EXCRETION;

EID: 0029881917     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169003     Document Type: Article

References (69)

1. US Renal Data System: USRDS 1990 Annual Data Report. Bcthesda. Md. The National Institutes of Health. National Institutes of Diabetes and Digestive and Kidney Diseases. 1990.
2. Weir MR: Hypertensive nephropathy: is a more physiologic approach to blood pressure control an important concern for the preservation of renal function? Am.1 Med 1992:93:275-375.
3. Pattinger WA, Lee HC, Reisch J, Mitchell HC: Long-term improvement in renal function after-short-term strict blood pressure control in hypertensive nephrosclerosis. Hypertension 1989: 13:766-772.
4. Rostand SC, Brown G, Kirk K, Rutsky EA, Dustan HP: Renal insufficiency in treated essential hypertension. N Engl J Med 1989:320:684 688.
5. Brazy PC, Stead WW, Fitzwilliam JF: Progression of renal insufficiency: role of blood pressure. Kidney Ini 1989:35:670-674.
6. Whelton PK. Klag MJ: Hypertension as a risk for renal disease: review of clinical and epidemiological evidence. Hypertension 1989: l7(Suppl. I): 199-227.
7. Klahr S, Levey AS, Sandberg AM, Williams G W: Jamor results of the feasibility study of the modification of diet in renal disease (MDRD study). Kidney Int 1989:35:195.
8. Tierney WM, McDonald CJ, Luft FC: Renal disease in hypertensive adults: effect of race and type II diabetes mellitus. Am J Kidney Dis 1989: 13:485-493.
9. Walker WG, Cutler J, Neuwirlh R, Neaion J: Blood pressure and renal function in the Multiple Risk Factor Intervention Trial (MRFIT). J Hypcrtens Suppl 1990:3:SI24.
10. Shulman NB, Ford CE, Hall WD. et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the Hypertension Detection and Follow-up Program. Hypertension 1989; 13(SuppI.):180-193.
11. Levey AS, Madaio MP, Perrone RO: Laboratory assessment of renal disease: clearance urinalysis and renal biopsy, in Bremmer B (ed): The Kidney. Philadelphia. WB Saunders. 1991, pp 940-941.
12. Rrenner BM. Hostetler TH. Humes HD: Molecular basis of proteinuria of glomerular orgin. N Engl J Med 1978:298:826-832.
13. Rennke HG., Olson JL, Venkatachalam MA: Glomerular filtration of macromolccules: normal mechanisms and the pathogenesis of proteinuria. Contrib Nephrol 1981:24:30 42.
14. Kannel WB, Stampfer MJ, Castelli WP, Verier J: The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984:108: 1347-1352.
15. Samuelson O, Wilhelmsen L, Elmfeldt D, Pen-nert K, Wedel H, Wikstrand J, Berglund G: Predictors of cardiovascular morbidity in treated hypertension results from the primary preventive trial in Göteborg. Sweden. J Hyper-tens 1985:3:167 176.
16. Bulpitt CJ, Beevers DG, Butler A, Coles EC, Hunt D, Munro-Faurr AD, Newson RB, Dol-lery CT: The survival of treated hypertensive patients and their causes of death: a report from the DHSS Hypertensive Care Computing Project (DHCCP). J Hypertens 1986:4:93 99.
17. Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertension: effect of an angiotensin converting enzyme inhibitor and a calcium channel blocker. Am J Hypertens 1991:4:291 296.
18. Bianehi S, Bigazzi R, Baldari G, Campese VM: Microalbuminuria in patients with essential hypertension: effect of several antihypertensive drugs. Am J Med 1992:93:525-528.
19. Karlbcrg B: Calcium antagonists in essential hypertension: effect on renal haemodynamics and microalbuminuria. J Intern Med 1992:231: 247-252.
20. Reams GP, Hamory A, Lau A, Bauer JH: Effect of nifedipine on renal function in patients with essential hypertension. Hypertension 1988:11: 452-456.
21. Reams GP, Lau A, Hamory A, Bauer JH: Amto-dipine therapy corrects renal abnormalities encountered in the hypertensive state. Am J Kidney Dis 1987:10:446-451.
22. Hartlbrt M, Wendelhag I, Berglund VG, Wal-lentin I, Ljungman S, Wikstrand R: Cardiovascular and renal effects of long-term antihyper-lensive treatment. JAMA 1988:259:2553-2557.
23. DeVenulo G, Andreotti C, Matterei M. Pegor-etti G: Long term captopril therapy at low doses reduces albumin excretion in patients with essential hypertension and no sign of renal impairment. J Hypcrtens Suppl 1985;3:S I43-S145.
24. Bigazzi R, Bianchi S. Baldari D, Sgherri G, Baldari G, Campese V: Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension. Am J Hypertens 1993;5:108-113.
25. Heeg JF, deJong PE, vanderHem GK, deZceuw D: Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989;36:272-279.
26. Campese VM, Parise M, Karubian F, Bigazzi R: Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 1991:18:805-821.
27. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM: Microalbuminuria in salt-sensitive patients: a making for renal and cardiovascular risk factors. Hypertension 1994:23: 195-199.
28. Weir MR, Dengel DR, Behrens MT, Goldberg AP: Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 1995:25:1339 1344.
29. Hunsicker LG, Adler S, Caggiulo A, England B, Greene T, Kusck J, Rogers N, Tischan P, MDRD study group. Relationships among baseline proteinuria, mean arterial pressure during follow-up. and decline in glomerular filtration rate in the modification of diet in renal disease study group. J Am Soc Nephrol 1993: 4:254.
30. Peterson JC, Burkart J, Greene T, Hebert L, Kung A, Klahr S, Massay S, Salten J, MDRD study group: The effect of blood pressure control on progression of renal disease depends on the level of proteinuria at baseline evaluation. J Am Soc Nephrol 1993:4:254.
31. Ruilopc LM. Miranda B. Morales JM. Rodicio JL. Romero JC. Raij L: Converting enzyme inhibition in chronic renal failure. Am J Kidney Dis 1989:13:120-126.
32. Zucchelli P, Zuccala A, Borghi M, Fusarole M, Sasdelli M, Stallone C, Sanne G, Gaggi R: Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992:42:452-458.
33. Kamper AL, Standgaard S, Leyssae PP: Effect of enalapril on the progression of chronic renal failure. A randomized control trial. Am J Hyp-ertens 1992:5:423-430.
34. Mattock MB, Morrish NJ, Vibert V, et al: Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992:41:736-741.
35. Parving I III, Oxenboll B, Svendsen PA. Christiansen JS, Anderson AR: Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol (Copcnh) 1982:100: 550 555.
36. Viberti GC, Hill RD, Jarret RD, Argyropoulos A, Mahmud U, Keen IT, Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982:i: 1430-1432.
37. Mogensen CE: Microalbuminuria predicts clinical: proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1986:310:356-360.
38. Christlich AR, Warram JH, Krolewski AS, et al: Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes 1981;30(Suppl. 2):90-96.
39. Mogensen CE: Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 1976;36:383-388.
40. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 1982:285:685-688.
41. Parving HH, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983;i: 1175-1179.
42. Parving HH, Andersen AR, Hommel E, Smidt U: Effects of long-term antihypertensive treatment of kidney function in diabetic nephropathy. Hypertension 1985;7(Suppl. 2): 114-117.
43. Zala R, Dunn BR, Meyer TW, Anderson S, Rennke HG. Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986:77:1925 1930.
44. Cooper ME. Allen TJ. MacMillan PA. Clarke BE. Jerums G. Doyle AE: Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rate. Diabetologia 1989:32:326-328.
45. Jackson B, Cubela R, Debrevi L, Whitty M, Johnston CI: Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or strcptozotocin-induced diabetes in the rat. J Cardiovasc Pharmacol 1987; l0(Suppl. 10):S167-S169.
46. Anderson S, Rennke HG, Garcia DL, Brenner BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989:36:526-536.
47. Cooper ME, Allen TJ, O'Brein RC, Rapazoglu D, Clarke BE, Jerums G, et al: Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. Diabetes 1990:39: 1575-1579.
48. Holdaas H, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald P, et al: Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. J Intern Med 1991: 229:163-170.
49. Baba T, Murabayashi S, Takebe K: Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomized, controlled trial. Diabetologia 1989:32:40 44.
50. Bjorck S, Mulee H, Johnsen SA, Nyberg G, Aurell M: Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BMJ 1990:300:904 907.
51. Stornello M, Valvo EV, Scapellalo L: Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy. J Cardiovasc Pharmacol 1989:14:851-855.
52. Bakris GL: Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 1990;112:707-708.
53. Stornello M, Valvo EV, Scapellato L: Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria. Nephron 1991: 58:52-57.
54. Demarie BK, Bakris GL: Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990: 113:987-988.
55. Bakris GL, Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic man: importance of therapeutic selection. Kidney Int 1992: 41:898-906.
56. Slataper S, Vieknair N, Sadler R, Bakris GL: Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993:153:973-980.
57. Kasiske BL, Kahl RSN, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regres-sion analysis. Ann Intern Med 1993:118:129-138.
58. Bjorck SS, Mulec H, Johnsen SA, Norden G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992:304:339-343.
59. Viberti G, Mogensen CE, Groop LC, Pauls JE, for the European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994:271:275-279.
60. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. for the Collaborative Study Group. The effect of angiotensin-converting-cnzymc inhibition on diabetic nephropathy. N Engl J Med 1993:329: 1456-1462.
61. Melbourne Diabetic Nephropathy Study Group: Comparison between perindopril and nifedipine in hypertensive and normotensivc diabetic patients with microalbuminuria. BMJ 1991;302:210-216.
62. Insua A, Ribstein J, Mimran A: Comparative effect of captopril and nifedipine in normoten-sive patients with incipient diabetic nephropathy. Postgrad Med J 1988:65(Suppl. 3):59-62.
63. Marrs M, Chatellier G, Leblance H, Guyene TT, Menard J, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988: 297:1092 1095.
64. Parving HH, Hommel E, Dampkjaer NM, Giese J: Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. BMJ 1989; 299:533-536.
65. Stornello M, Valvo EV, Scapellato L: Angiotensin coverting enzyme inhibition in normotensive type II diabetics with persistent mild proteinuria. J Hvpertens Suppl 1989;6:S3I4-S3I5.
66. Rudbcrg S, Aperia A, Freyschuss U, Persson B: Enalapril reduces microalbuminuria in young normotensive type I (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990:33:470 476.
67. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type 11 diabetic patients. Ann Intern Med 1993:118:577 581.
68. Yoshioka T, Shiraga H, Yoshida Y, et al: Intact nephrons as the primary origin of proteinuria in chronic renal disease study in the rat model of subtotal nephrectomy. J Clin Invest 1988:82: 1614-1623.
69. Kerlani T, Schlueter WA, Levin ML, Battle DC: Improvement of lipid abnormalities associated with proteinuria using fosinopril. an angiotensin-converting enzyme inhibitor. Ann Intern Med 1993:118:246-254.